Skandinaviska Enskilda Banken (SEB)’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-8,028
Closed -$1.97M 928
2022
Q3
$1.97M Sell
8,028
-4,684
-37% -$1.26M 0.02% 549
2022
Q2
$3.15M Buy
12,712
+1,054
+9% +$284K 0.02% 463
2022
Q1
$3.86M Sell
11,658
-1,301
-10% -$400K 0.02% 462
2021
Q4
$4.69M Sell
12,959
-986
-7% -$333K 0.02% 433
2021
Q3
$4.54M Buy
13,945
+856
+7% +$290K 0.02% 436
2021
Q2
$4.08M Buy
13,089
+72
+0.6% +$22.1K 0.03% 464
2021
Q1
$4.15M Buy
13,017
+925
+8% +$296K 0.03% 435
2020
Q4
$3.92M Sell
12,092
-34,131
-74% -$9.44M 0.03% 432
2020
Q3
$12.8M Buy
46,223
+5,192
+13% +$1.5M 0.09% 199
2020
Q2
$9.91M Buy
41,031
+33,555
+449% +$6.74M 0.08% 228
2020
Q1
$1.08M Sell
7,476
-1,446
-16% -$240K 0.01% 631
2019
Q4
$1.52M Buy
8,922
+979
+12% +$182K 0.01% 625
2019
Q3
$1.41M Buy
7,943
+1,263
+19% +$273K 0.01% 622
2019
Q2
$1.74M Sell
6,680
-47,277
-88% -$12.5M 0.02% 555
2019
Q1
$15.4M Buy
53,957
+40,367
+297% +$13.4M 0.14% 141
2018
Q4
$4.42M Buy
13,590
+1,201
+10% +$417K 0.04% 295
2018
Q3
$5.57M Buy
12,389
+6,200
+100% +$2.44M 0.04% 281
2018
Q2
$2.53M Buy
+6,189
New +$2.24M 0.02% 383

Other funds holding ABMD

Skandinaviska Enskilda Banken (SEB)'s ABMD Position: Q4 2022 in Review

Skandinaviska Enskilda Banken (SEB) sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 8,028 shares — an estimated $1.97M sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in ABMD in Q2 2018 and held it in 18 quarters. The position peaked at $15.4M in Q1 2019. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Skandinaviska Enskilda Banken (SEB) reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Skandinaviska Enskilda Banken (SEB) sold 8,028 Abiomed Inc shares in Q4 2022, an estimated $1.97M.
  • Skandinaviska Enskilda Banken (SEB) first reported a position in Abiomed Inc in Q2 2018 and held it in 18 quarters.
  • Skandinaviska Enskilda Banken (SEB)'s Abiomed Inc position peaked at $15.4M in Q1 2019.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q4 2022, filed 8 Feb 2023.